Compare Moderna, Inc. (MRNA) vs VF Corp (VFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs VF Corp — how do they compare? Moderna, Inc. trades at $60.83 (market cap $24.18B), while VF Corp trades at $14.9 (market cap $5.81B). The key difference: Moderna, Inc. is far larger — about 4.2× VF Corp's market cap, and VF Corp pays a 2.44% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | VFC | |
|---|---|---|
Market Cap | $24.18B | $5.81B |
Sector | Health | Consumer Cyclical |
52-Week High | $81.80 | $21.55 |
52-Week Low | $22.36 | $12.21 |
Enterprise Value | $20.33B | $10.09B |
Dividend Yield | — | 2.44% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About VF Corp
VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →
